Brigham and Women's Hospital and Harvard Medical School — Omicron Detection

A study from Brigham and Women’s Hospital and Harvard Medical School found that BinaxNOW detects Omicron at rates comparable to previous variants.

• Participants were found after testing positive for COVID-19 through PCR tests at an academic medical center
• BinaxNOW was able to detect Omicron and Delta viral concentrations of 100,000 copies per swab or greater
• Study shows that BinaxNOW rapid antigen tests can detect the Omicron variant

Johns Hopkins School of Medicine — Test Accuracy in Kids

Researchers from Johns Hopkins School of Medicine found that BinaxNOW had 92.7% sensitivity and 98% specificity among the 1,054 pediatric study participants.

• Study was focused on testing children as they can be significant spreaders of the disease and the inability to detect infections can disrupt in-person education
• Delta was the predominant variant during testing period
• Determined that highly accurate rapid antigen tests may be vital to containing the spread of COVID-19 and minimizing detrimental effects

University of California San Francisco — Asymptomatic Detection

A real-world study from the University of California San Francisco showed BinaxNOW detects COVID-19 among people regardless of symptoms

• Study conducted at a public plaza site during ongoing community transmission in September 2020
• 878 participants
• Study found that BinaxNOW demonstrated a sensitivity of 93.3% and specificity of 99.9% in high viral load samples

With the ability to provide reliable COVID-19 results when and where they're needed most, individuals can quarantine appropriately and help minimize the spread — something even more crucial with the current Omicron variant.